Literature DB >> 22367197

Structural characterization of Streptococcus pneumoniae serotype 9A capsule polysaccharide reveals role of glycosyl 6-O-acetyltransferase wcjE in serotype 9V capsule biosynthesis and immunogenicity.

Juan J Calix1, Jamil S Saad, Allison M Brady, Moon H Nahm.   

Abstract

The putative capsule O-acetyltransferase gene wcjE is highly conserved across various Streptococcus pneumoniae serotypes, but the role of the gene in capsule biosynthesis and bacterial fitness remains largely unclear. Isolates expressing pneumococcal serotype 9A arise from precursors expressing wcjE-associated serotype 9V through loss-of-function mutation to wcjE. To define the biosynthetic role of 9V wcjE, we characterized the structure and serological properties of serotype 9V and 9A capsule polysaccharide (PS). NMR data revealed that both 9V and 9A PS are composed of an identical pentasaccharide repeat unit, as reported previously. However, in sharp contrast to previous studies on 9A PS being devoid of any O-acetylation, we identified O-acetylation of α-glucuronic acid and α-glucose in 9A PS. In addition, 9V PS also contained -CH(2) O-acetylation of β-N-acetylmannosamine, a modification that disappeared following in vitro recombinatorial deletion of wcjE. We also show that serotyping sera and monoclonal antibodies specific for 9V and 9A bound capsule PS in an O-acetate-dependent manner. Furthermore, IgG and to a lesser extent IgM from human donors immunized with serotype 9V PS displayed stronger binding to 9V compared with 9A PS. We conclude that serotype 9V wcjE mediates 6-O-acetylation of β-N-acetylmannosamine. This PS modification can be selectively targeted by antibodies in immunized individuals, identifying a potential selective advantage for wcjE inactivation and serotype 9A emergence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367197      PMCID: PMC3340191          DOI: 10.1074/jbc.M112.346924

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Streptococcus pneumoniae serotype 9A isolates contain diverse mutations to wcjE that result in variable expression of serotype 9V-specific epitope.

Authors:  Juan J Calix; Melissa B Oliver; Logan K Sherwood; Bernard W Beall; Susan K Hollingshead; Moon H Nahm
Journal:  J Infect Dis       Date:  2011-09-09       Impact factor: 5.226

2.  Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution.

Authors:  Juan J Calix; Ron Dagan; Stephen I Pelton; Nurith Porat; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilus influenzae, identification of a gene for adding O-acetyl groups.

Authors:  Kate L Fox; Håkan H Yildirim; Mary E Deadman; Elke K H Schweda; E Richard Moxon; Derek W Hood
Journal:  Mol Microbiol       Date:  2005-10       Impact factor: 3.501

5.  Identification of the common antigenic determinant shared by Streptococcus pneumoniae serotypes 35A and 20 capsular polysaccharides--structural analysis of the Streptococcus pneumoniae serotype 35A capsular polysaccharide.

Authors:  L M Beynon; J C Richards; M B Perry
Journal:  Eur J Biochem       Date:  1997-11-15

6.  The specific capsular polysaccharide of Streptococcus pneumoniae type 15F.

Authors:  M B Perry; D R Bundle; V Daoust; D J Carlo
Journal:  Mol Immunol       Date:  1982-02       Impact factor: 4.407

7.  Location and quantitation of the sites of O-acetylation on the capsular polysaccharide from Streptococcus pneumoniae type 9V by 1H-n.m.r. spectroscopy: comparison with type 9A.

Authors:  T J Rutherford; C Jones; D B Davies; A C Elliott
Journal:  Carbohydr Res       Date:  1991-09-30       Impact factor: 2.104

8.  Structure of the capsular polysaccharide of pneumococcal serotype 11A reveals a novel acetylglycerol that is the structural basis for 11A subtypes.

Authors:  Edward R Zartler; Richard J Porambo; Carrie L Anderson; Lorenzo H Chen; Jigui Yu; Moon H Nahm
Journal:  J Biol Chem       Date:  2008-12-29       Impact factor: 5.157

9.  Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques.

Authors:  T B McNeely; J M Staub; C M Rusk; M J Blum; J J Donnelly
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.

Authors:  David S Berry; Freyja Lynn; Che-Hung Lee; Carl E Frasch; Margaret C Bash
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  20 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.

Authors:  Brady L Spencer; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype.

Authors:  Juan J Calix; Richard J Porambo; Allison M Brady; Thomas R Larson; Janet Yother; Chitrananda Abeygunwardana; Moon H Nahm
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

4.  Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneumococcal strain producing three different capsular repeat units.

Authors:  In Ho Park; K Aaron Geno; Jigui Yu; Melissa B Oliver; Kyung-Hyo Kim; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

5.  Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation.

Authors:  Juan J Calix; Allison M Brady; Victor Y Du; Jamil S Saad; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

6.  Complement activation by human IgG antibodies to galactose-α-1,3-galactose.

Authors:  Jens Magnus Bernth Jensen; Nick Stub Laursen; Rasmus Kjeldsen Jensen; Gregers Rom Andersen; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2020-07-14       Impact factor: 7.397

7.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Commercially available complement component-depleted sera are unexpectedly codepleted of ficolin-2.

Authors:  Allison M Brady; K Aaron Geno; Alex G Dalecki; Xiaogang Cheng; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2014-07-16

9.  Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units.

Authors:  Melissa B Oliver; Mark P G van der Linden; Sharon A Küntzel; Jamil S Saad; Moon H Nahm
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

10.  Chemical structures of Streptococcus pneumoniae capsular polysaccharide type 39 (CPS39), CPS47F, and CPS34 characterized by nuclear magnetic resonance spectroscopy and their relation to CPS10A.

Authors:  C Allen Bush; Jinghua Yang; Bingwu Yu; John O Cisar
Journal:  J Bacteriol       Date:  2014-07-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.